
|Videos|December 19, 2022
2022 SUO Annual Meeting recap: Use of doublet therapy in metastatic prostate cancer varies by location
Author(s)Urology Times staff
“This study highlights how treatment remains influenced by where you live,” Diana Magee, MD, MPH, MSc.
Advertisement
In this video, Diana Magee, MD, MPH, MSc, summarizes the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5











